Our solutions
Our medicinal cannabis products and services are backed by rigorous quality standards to improve patients' lives.
Products and Services Portfolio
Dry Flower
Our high-quality medicinal cannabis flowers are the result of our commitment to excellence and compliance with the highest regulatory standards.
Extracts
We can manufacture and supply THC and CBD full-spectrum extracts, cannabis oil and balanced formulations. Based on strategic partnerships, we can manufacture and supply the highest quality products ready to be marketed under the customer’s own brand.
- Supply of full-spectrum THC and CBD for formulation purposes (bulk).
- Medicinal cannabis oil at different strengths.
- Supply of Dronabinol (API) complying with German monograph (DAC_D-100) in different formats (syringes and bottles).
All Linneo Health products comply with the highest quality standards following EU-GMP requirements.
For more information, please contact our sales department.
All Linneo Health products comply with the highest quality standards following EU-GMP requirements.
Services
We offer cutting-edge analytical services with a laboratory equipped with the latest technical advances and highly trained professionals. We also provide professional advice to our clients and perform GMP processing services for the Cannabis sativa flower.
Laboratory
We have one of the most sophisticated and well-equipped EU-GMP certified analytical parks in the industry. We also have a highly qualified and committed technical team with extensive experience in the sector. Our laboratory allows us to perform all analytical techniques necessary to prepare a complete certificate of analysis of the Cannabis flower, allowing us to work more quickly and reliably.
Stability studies
Intermediate (30ºC ± 2ºC/65% RH ± 5% RH)
Accelerated (40ºC ± 2ºC/75% RH ± 5% RH)
Quality control in purified water
Microbiologic analyses
Quality control cannabis derived product
Identification microscopic and macroscopic / Foreign materials - Content Analyses by HPLC-DAD and HPLC Identification - Cannabis Profile by HPLC-DAD: delta-9-tetrahydrocannabinol (THC), delta-9-tetrahydrocannabinolic acid (THC-A), cannabidiol (CBD), cannabidiolic acid (CBD-A), delta-8-tetrahycrocannabinol (THC). cannabinol (CBN), cannabichromene (CBC), cannabichromene acid (CBCA), canaigre (CBG), cannabigerol acid (CBGA), delta-9- tetrahydrocannabivarin (THVC), cannabidivarin (CBDV) - Determination of Moisture by Loss on Drying in Vacuum Oven and Karl Fisher - Mycotoxin Analyses: Afltoxin and Ochratoxin A - Heavy Metals : Cadmium, Mercury, Lead and Arsenic, Niquel, Zinc - Total Ash and Sulfuric Ash - Analyses of pesticides: multiresidue pesticides - Terpene profile
MICROBIOLOGICAL ANALYSES.
- Mold and Yeast (TYMC) - Total Aerobes (TAMC) - Enterobacteria, Pseudomonas aeruginosa, Staphyloccoccus aureus, Escherichia coli, Salmonella spp, Shigella spp, Listeria Monocytogene
Consultancy
We provide specialised advice to address any medicinal cannabis need. We stand side-by-side with our clients at all stages of the process, from analytics, cultivation, production and marketing of medicinal cannabis, creating qualified and innovative solutions according to their needs.
GMP Processing
GMP processing of the Cannabis sativa flower: Linneo has an EU-GMP certificate for active substances, as well as for the finished product (EU-GMP part I and part II), which allows us to offer multiple options, depending on the requirements needed to obtain the desired final product.
Commercial Team and Markets
Linneo Health’s commercial team comprises a group of professionals with vast experience in the pharmaceutical industry and regulated cannabis market. With a strong track record in management and strategic development roles, the team is prepared to address the most complex business challenges.
The team is focused on company growth in emerging markets, with experience spanning global functions, general management, marketing and commercial operations in various traditional pharmaceutical companies, both in the B2C and B2B spheres. Linneo Health is dedicated to managing accounts throughout Europe and seeks business opportunities in new territories. We are particularly interested in opportunities in countries such as Germany as it pioneers medicinal cannabis in Europe.
Our team is distinguished by its experience in business development, business process integration and technological assets. We have worked in various regions, including Europe, LATAM and United States, allowing adaptability in diverse markets. At Linneo Health, we maximise results through solid and effective strategies.
